RxDoctor Payments Data

Nestor Praderio, MD

Psychiatry · Corpus Christi, TXNPI 1144265562

Payments from drug & device makers

$7,803in general payments, 2019–2025

Across 457 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Lundbeck LLC$895
  • Otsuka America Pharmaceutical, Inc.$663
  • AbbVie$646
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$637
  • Sunovion Pharmaceuticals Inc.$633
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$7,782100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,803 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$59,014
Medicare patients
252
Services billed
586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole31$51,630
VraylarCariprazine Hcl16$33,830
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine328$10,765
Lisdexamfetamine Dimesylate51$9,556
TrintellixVortioxetine Hydrobromide19$9,026
VyvanseLisdexamfetamine Dimesylate23$8,743
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine109$5,526
Memantine Hcl138$3,991
Aripiprazole48$3,893
Rivastigmine24$3,814
Duloxetine Hcl165$3,443
Bupropion XlBupropion Hcl60$2,930
Clonazepam225$2,772
Divalproex Sodium51$2,560
Quetiapine Fumarate126$2,434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$663$51,63031 claims
AbbVieVraylar$646$33,83016 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$420$17,76942 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →